Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Inmode Ltd (INMD)

Inmode Ltd (INMD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,393,703
  • Shares Outstanding, K 31,973
  • Annual Sales, $ 156,360 K
  • Annual Income, $ 61,150 K
  • 60-Month Beta 2.11
  • Price/Sales 8.85
  • Price/Cash Flow 22.53
  • Price/Book 5.94
Trade INMD with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate 0.55
  • Number of Estimates 1
  • High Estimate 0.55
  • Low Estimate 0.55
  • Prior Year 0.46
  • Growth Rate Est. (year over year) +19.57%

Price Performance

See More
Period Period Low Period High Performance
1-Month
36.04 +20.95%
on 10/30/20
45.00 -3.13%
on 11/09/20
+2.10 (+5.06%)
since 10/23/20
3-Month
29.15 +49.54%
on 09/01/20
45.00 -3.13%
on 11/09/20
+11.20 (+34.58%)
since 08/25/20
52-Week
13.14 +231.74%
on 03/18/20
54.90 -20.60%
on 11/27/19
-4.07 (-8.54%)
since 11/25/19

Most Recent Stories

More News
Is InMode (INMD) Outperforming Other Medical Stocks This Year?

Is (INMD) Outperforming Other Medical Stocks This Year?

INMD : 43.59 (+0.69%)
Oasis Treatment Tent by La Belle Vie MedSpa featuring InMode

, /PRNewswire/ -- La Belle Vie MedSpa & Wellness Center is proud to announce the grand opening of the Oasis Treatment Tent, a luxury COVID-friendly experience in a private outdoor setting, featuring InMode's...

INMD : 43.59 (+0.69%)
Zacks.com featured highlights include: Catalyst Biosciences, UFP Industries, VeriSign, InMode and Castle Biosciences

Zacks.com featured highlights include: Catalyst Biosciences, UFP Industries, VeriSign, InMode and Castle Biosciences

UFPI : 54.05 (-0.83%)
VRSN : 198.72 (+0.64%)
CBIO : 5.80 (+1.93%)
INMD : 43.59 (+0.69%)
CSTL : 43.60 (-2.94%)
InMode: 3Q Earnings Snapshot

YOKNEAM, Israel (AP) _ InMode Ltd. (INMD) on Thursday reported third-quarter profit of $23.9 million.

INMD : 43.59 (+0.69%)
InMode Reports Record Third Quarter 2020 Financial Results; Quarterly Revenues of $59.7 Million Represent 49% Year over Year Growth, GAAP and *Non-GAAP Diluted Earnings per Share of $0.57 and $0.63

YOKNEAM, Israel, /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced consolidated financial results for its third quarter...

INMD : 43.59 (+0.69%)
Inmode Ltd to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / November 12, 2020 / Inmode Ltd (NASDAQ:INMD) will be discussing their earnings results in their 2020 Third Quarter Earnings call to be held on November 12, 2020 at 8:30 AM Eastern...

INMD : 43.59 (+0.69%)
Nanowear Receives FDA 510(k) Clearance for SimpleSENSE, a Cloth-Based Wearable Remote Diagnostic Monitoring Platform

, /PRNewswire/ -- Nanowear , the leading connected-care and remote diagnostic platform, today announced it has received FDA Class II 510(k) clearance for a first-of-its-kind cloth-based diagnostic platform,...

INMD : 43.59 (+0.69%)
5 Stocks Set to Pop on New Analyst Coverage

Increased analyst coverage over the last few weeks might lead to solid price appreciation for stocks like Catalyst Biosciences (CBIO), UFP Industries (UFPI), VeriSign (VRSN), InMode (INMD) and Castle Biosciences...

UFPI : 54.05 (-0.83%)
VRSN : 198.72 (+0.64%)
CBIO : 5.80 (+1.93%)
INMD : 43.59 (+0.69%)
CSTL : 43.60 (-2.94%)
Stock Investors: What's the Next Hot Industry?

Technology won't always be on top. There's a bunch of budding industries that could prove to be winners over the next 5 years.

XLK : 122.01 (+0.21%)
QQQ : 296.28 (+0.61%)
EXAS : 115.87 (-1.19%)
VCEL : 24.96 (+7.73%)
INMD : 43.59 (+0.69%)
Find Strong Stocks with this New Analyst Coverage Screener

Find Strong Stocks with this New Analyst Coverage Screener

INMD : 43.59 (+0.69%)
GRBK : 22.92 (-2.39%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

InMode Ltd. is a provider of medical technologies. It develops, manufactures and markets devices harnessing novel radio-frequency technology. The company serves plastic surgery, gynecology, dermatology, otolaryngology and ophthalmology. InMode Ltd. is based in Yokneam, Israel.

See More

Key Turning Points

2nd Resistance Point 44.93
1st Resistance Point 44.26
Last Price 43.59
1st Support Level 42.95
2nd Support Level 42.31

See More

52-Week High 54.90
Last Price 43.59
Fibonacci 61.8% 38.95
Fibonacci 50% 34.02
Fibonacci 38.2% 29.09
52-Week Low 13.14

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar